Cargando…

Stimuli-responsive platinum and ruthenium complexes for lung cancer therapy

Lung cancer is the most common cause of cancer-related deaths worldwide. More efficient treatments are desperately needed. For decades, the success of platinum-based anticancer drugs has promoted the exploration of metal-based agents. Four ruthenium-based complexes have also entered clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Cheng, Kang, Tong, Wang, Xinyi, Song, Jiaqi, Zhang, Jia, Li, Guanying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618881/ https://www.ncbi.nlm.nih.gov/pubmed/36324675 http://dx.doi.org/10.3389/fphar.2022.1035217

Ejemplares similares

Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
por: Lin, Ke, et al.
Publicado: (2018)

Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy
por: Yusoh, Nur Aininie, et al.
Publicado: (2020)

Binding of Stimuli-Responsive Ruthenium Aqua Complexes with 9-Ethylguanine
por: Maeda, Atsuki, et al.
Publicado: (2023)

Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment
por: Mahmud, Kazi Mustafa, et al.
Publicado: (2021)

Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy
por: Liu, Jia-Si, et al.
Publicado: (2023)

Bioorthogonal Catalytic Activation of Platinum and Ruthenium Anticancer Complexes by FAD and Flavoproteins
por: Alonso‐de Castro, Silvia, et al.
Publicado: (2018)

Ruthenium Complexes as Promising Candidates against Lung Cancer
por: Sun, Qi, et al.
Publicado: (2021)

Phenethylisothiocyanate Potentiates Platinum Therapy by Reversing Cisplatin Resistance in Cervical Cancer
por: Mahapatra, Elizabeth, et al.
Publicado: (2022)

Half-Sandwich Arene Ruthenium(II) Thiosemicarbazone Complexes: Evaluation of Anticancer Effect on Primary and Metastatic Ovarian Cancer Cell Lines
por: Guler, Seminay, et al.
Publicado: (2022)

An Overview of Stimuli-Responsive Intelligent Antibacterial Nanomaterials
por: Zhang, Jinqiao, et al.
Publicado: (2023)

Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence
por: Fridley, Brooke L., et al.
Publicado: (2016)

Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer
por: Mondal, Priya, et al.
Publicado: (2023)

Proteomic and Bioinformatic Studies for the Characterization of Response to Pemetrexed in Platinum Drug Resistant Ovarian Cancer
por: Severi, Leda, et al.
Publicado: (2018)

[Ru(bpy)(2)(NO)SO(3)](PF(6)), a Nitric Oxide Donating Ruthenium Complex, Reduces Gout Arthritis in Mice
por: Rossaneis, Ana C., et al.
Publicado: (2019)

Nanocarriers containing platinum compounds for combination chemotherapy
por: Fang, Guihua, et al.
Publicado: (2022)

Systemic Evaluation on the Pharmacokinetics of Platinum-Based Anticancer Drugs From Animal to Cell Level: Based on Total Platinum and Intact Drugs
por: Qin, Zhiying, et al.
Publicado: (2020)

LINC-PINT suppresses cisplatin resistance in gastric cancer by inhibiting autophagy activation via epigenetic silencing of ATG5 by EZH2
por: Zhang, Cheng, et al.
Publicado: (2022)

The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy
por: Zou, Ting, et al.
Publicado: (2020)

Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World Study
por: Li, Xin, et al.
Publicado: (2021)

The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
por: Zhou, Jiabei, et al.
Publicado: (2020)

Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance
por: Lin, Xixi, et al.
Publicado: (2019)

Ruthenium(II) and Platinum(II) Complexes with Biologically Active Aminoflavone Ligands Exhibit In Vitro Anticancer Activity
por: Fabijańska, Małgorzata, et al.
Publicado: (2021)

Ruthenium atomically dispersed in carbon outperforms platinum toward hydrogen evolution in alkaline media
por: Lu, Bingzhang, et al.
Publicado: (2019)

Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
por: Tian, Hao, et al.
Publicado: (2021)

Cost-effectiveness analysis of olaparib as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation in china
por: Shu, Yamin, et al.
Publicado: (2022)

Neglected, Drug-Induced Platinum Accumulation Causes Immune Toxicity
por: Zhang, Yuling, et al.
Publicado: (2020)

In Metastatic Non-small cell Lung Cancer Platinum-Based Treated Patients, Herbal Treatment Improves the Quality of Life. A Prospective Randomized Controlled Clinical Trial
por: Guo, Huiru, et al.
Publicado: (2017)

Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance
por: Lin, Xixi, et al.
Publicado: (2022)

Synergetic interaction between neighboring platinum and ruthenium monomers boosts CO oxidation
por: Zhou, Peng, et al.
Publicado: (2019)

Rationally Designed Ruthenium Complexes for Breast Cancer Therapy
por: Golbaghi, Golara, et al.
Publicado: (2020)

Ruthenium Chloride—Induced Oxidative Cyclization of Trans-Resveratrol to (±)-ε-Viniferin and Antimicrobial and Antibiofilm Activity Against Streptococcus pneumoniae
por: Yadav, Mukesh Kumar, et al.
Publicado: (2019)

Huisheng Oral Solution Adjunct With Platinum-Based Chemotherapy for the Treatment of Advanced Non–Small Cell Lung Cancer: A Meta-Analysis and Systematic Review
por: Huang, Jingyi, et al.
Publicado: (2020)

Platinum Accumulation and Cancer-Related Fatigue, Correlation With IL-8, TNF-α and Hemocytes
por: Zhang, Yuling, et al.
Publicado: (2021)

Non-Coding RNA Polymorphisms (rs2910164 and rs1333049) Associated With Prognosis of Lung Cancer Under Platinum-Based Chemotherapy
por: Chen, Yi-Xin, et al.
Publicado: (2021)

Genetic Variants in Double-Strand Break Repair Pathway Genes to Predict Platinum-Based Chemotherapy Prognosis in Patients With Lung Cancer
por: Liu, Jun-Yan, et al.
Publicado: (2022)

The platinum coordination complex inhibits cell invasion-migration and epithelial-to-mesenchymal transition by altering the TGF-β-SMAD pathway in colorectal cancer
por: Abdulla, Maha-Hamadien, et al.
Publicado: (2023)

Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes
por: Dragutan, Ileana, et al.
Publicado: (2015)

Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis
por: Liu, Xiaoyan, et al.
Publicado: (2022)

Role of transporters in the distribution of platinum-based drugs
por: Harrach, Saliha, et al.
Publicado: (2015)

Recent Advance in Tumor Microenvironment-Based Stimuli-Responsive Nanoscale Drug Delivery and Imaging Platform
por: Cui, Fengzhi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o559fn9dont2v1r9hh57r2lute